CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities
Net loss	$ (301,711,000)	$ (1,009,678,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	80,690,000	11,738,000
Amortization of insurance premium	14,924,000	2,747,000
Non-cash operating lease cost	8,952,000	13,502,000
Stock-based compensation	268,943,000	129,244,000
Amortization of debt discounts and issuance costs	2,409,000	0
Inventory write-downs	178,057,000	0
Change in fair value of contingent forward contract liability	0	454,546,000
Other non-cash items	(5,000)	56,000
Changes in operating assets and liabilities:
Accounts receivable	1,608,000	(220,000)
Inventory	(603,852,000)	(27,181,000)
Prepaid expenses	6,459,000	(22,183,000)
Other current assets	(32,199,000)	(2,380,000)
Other noncurrent assets	(27,556,000)	(3,870,000)
Accounts payable	49,596,000	(11,871,000)
Accrued compensation	23,186,000	7,990,000
Operating lease liability	(6,944,000)	(7,742,000)
Other current liabilities	179,544,000	633,000
Other long-term liabilities	7,795,000	3,889,000
Net cash used in operating activities	(1,008,277,000)	(453,804,000)
Cash flows from investing activities:
Purchases of property, plant and equipment	(494,900,000)	(206,533,000)
Proceed from sale of property, plant and equipment	0	19,000
Purchases of investments	(1,419,223,000)	0
Net cash used in investing activities	(1,914,123,000)	(206,514,000)
Cash flows from financing activities:
Payment for short-term insurance financing note	(15,330,000)	(2,747,000)
Payment for finance lease liabilities	(2,401,000)	(1,364,000)
Proceeds from short-term insurance financing note	0	10,950,000
Proceeds from borrowings	6,663,000	0
Proceeds from exercise of stock options	12,849,000	5,266,000
Proceeds from employee stock purchase plan	12,882,000	0
Stock repurchases from employees for tax withholdings	(191,241,000)	0
Payment for credit facility issuance costs	(6,631,000)	0
Net cash (used in) provided by financing activities	(183,209,000)	612,105,000
Net decrease in cash, cash equivalents, and restricted cash	(3,105,609,000)	(48,213,000)
Beginning cash, cash equivalents, and restricted cash	6,298,020,000	640,418,000
Ending cash, cash equivalents, and restricted cash	3,192,411,000	592,205,000
Supplemental disclosure of cash flow information:
Cash paid for interest, net of amounts capitalized	12,282,000	198,000
Cash paid for taxes	480,000	0
Supplemental disclosure of non-cash investing and financing activity:
Increases (decreases) in purchases of property, plant and equipment included in accounts payable and accrued expenses	17,240,000	(24,661,000)
Property, plant and equipment and right-of-use assets obtained through leases	47,022,000	4,437,000
Issuance of Series D convertible preferred stock upon exercise of preferred stock warrants	0	9,936,000
Issuance of Series E convertible preferred stock contingent forward contracts	0	2,167,332,000
Capital contribution upon forfeit of Series E awards	0	15,719,000
Capital leases retired upon adoption of new lease accounting standard	0	3,257,000
Change in fair value of preferred stock warrant liability
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of stock warrants liability	0	6,976,000
Change in fair value of common stock warrant liability
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of stock warrants liability	(858,173,000)	0
Series B
Cash flows from financing activities:
Repurchase of Series B convertible preferred stock	0	(3,000,000)
Series D
Cash flows from financing activities:
Proceeds from issuance of convertible preferred stock	0	3,000,000
Series E
Cash flows from financing activities:
Proceeds from issuance of convertible preferred stock	0	600,000,000
Supplemental disclosure of non-cash investing and financing activity:
Issuance of Series E convertible preferred stock upon settlement of contingent forward contracts		$ (2,621,878,000)